Status: current, Primitive. Date: 30-Jun 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 21681000168110 | Seretide MDI 50/25 (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 21691000168113 | Seretide MDI 50/25 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Seretide MDI 50/25 | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Seretide MDI 50/25 inhalation, actuation | Is a | True | Seretide MDI 50/25 | Inferred relationship | Some | |
| Seretide MDI 50/25 inhalation, 120 actuations | has TP | True | Seretide MDI 50/25 | Inferred relationship | Some | |
| Seretide MDI 50/25 (fluticasone propionate 50 microgram / 1 actuation + salmeterol 25 microgram / 1 actuation) inhalation, 120 actuations, aerosol can (containered trade product pack) | has TP | True | Seretide MDI 50/25 | Inferred relationship | Some |
Reference Sets
FHIR